The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.

A new PET/CT imaging technique that visualizes activated fibroblasts in the heart muscle enables early detection of multiple ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...

The fight against cancer in the country has received another major boost after Nairobi West Hospital announced that it had ...

Dr. Kevin Leung presented an artificial intelligence-based risk score for the prognostic evaluation of prostate cancer patients using PSMA PET/CT imaging. Dr. Leung argued that improved survival ...

Determining the specific type of dementia early in the diagnostic process can lead to more targeted treatments and better outcomes ...

Dave Coulier recalled the moment he got diagnosed with cancer, his immunity problems after chemotherapy, and the beacons of ...

For the first time, a new PET imaging technique has successfully visualized three radiotracers in a single scan, according to ...

FDA approved to help select patients with metastatic prostate cancer for radioligand therapy before chemotherapy.

PET/CT findings will be defined as true negative (TN), if the scan was negative and no distant disease was detected during further follow-up. PET/CT results will be defined as false negative (FN), if ...